BeyondSpring is trading 5.42% up now at $0.76, mainly linked to stronger biotech sentiment, with no new company-specific announcement identified for August 19, 2026.

  • The XBI sector benchmark is up 2.27% pre-market.
  • Its August 14 earnings update highlighted DUBLIN-4 preparations and positive Phase 2 survival data.
  • Limited liquidity makes that report supporting background rather than a fresh catalyst.